New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in prostate ...

The FDA has approved a once-daily autoinjector for zilucoplan (ZILBRYSQ), giving adults with generalized myasthenia gravis (gMG) a second self-administered delivery option for the ...

For the last two years, I have been writing about the promise of Artificial Intelligence, noting the extraordinary, ...

The Chiefs came storming out of the bye week with a 22-6 drubbing of the Los Angeles Chargers on Sunday at Arrowhead Stadium.

The companies and individuals behind these technologies are among the honorees in Fast Company’s Next Big Things in Tech ...

Biohub, the U.S. Department of Energy, the National Institutes of Health and private-sector partners have announced a coordinated $1.8 billion commitment of funding, data, computing resources and ...

Inc. announced positive progress in GFH375/VS-7375?s clinical development with latest data disclosed from multiple studies in China and abroad. In China, GFH375 has received three Breakthrough Therapy ...

Capitalizing on a Global Hair Restoration Market Projected to Exceed $23 Billion, the Venture Integrates Advanced Exosome Delivery to Eliminate Microneedling and Reactivate Follicles ORLANDO, FL / ACC ...

Australia 1st Test live match scorecard. Follow along with the latest live scorecard here as the match unfolds, or ...

In a major clinical breakthrough offering natural, non-invasive relief to parents and pediatricians, a clinical study ...

We all know that what we eat has a massive impact on our health. But now there’s evidence that our diet – more specifically, the timing of our meals – could actually help treat serious illness and ...